Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
about
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report.
P2860
Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@en
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@nl
type
label
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@en
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@nl
prefLabel
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@en
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Carboxymethyl lysine, an advan ...... rt analysis of the ARIC Study.
@en
P2093
B B Duncan
L E Chambless
M I Schmidt
P2860
P304
P356
10.1111/DME.12963
P577
2015-09-11T00:00:00Z